Herbas VPB

Print
EN | LT
LT - ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES
EN - ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/2803 (2013.01)
C07K 16/28 (2006.01)
A61P 35/00 (2006.01)
C07K 16/2827 (2013.01)
A61K2039/505 (2013.01)
C07K2317/31 (2013.01)
C07K2317/55 (2013.01)
C07K2317/64 (2013.01)
C07K2317/71 (2013.01)
C07K2317/73 (2013.01)
C07K2317/92 (2013.01)
C07K2317/94 (2013.01)
A61K 31/351 (2013.01)
A61P 35/00 (2018.01)
A61K2039/507 (2013.01)
A61K 31/4164 (2013.01)
A61K 33/243 (2019.01)
European patent
(11) Number of the document 3609920
(13) Kind of document T
(96) European patent application number 18720834.3
Date of filing the European patent application 2018-04-04
(97) Date of publication of the European application 2020-02-19
(45) Date of publication and mention of the grant of the patent 2023-07-12
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2018/026060
Date 2018-04-04
PCT application publication
(87) Number WO 2018/191074
Date 2018-10-18
Priority applications
(30) Number Date Country code
201762484025 P 2017-04-11 US
Inventors
(72)
D'ANGELO, Igor Edmondo Paolo , CA
LI, Yiwen , US
LUDWIG, Dale Lincoln , US
SHEN, Yang , US
ZHANG, Yi , US
Grantee
(73) Eli Lilly and Company , Lilly Corporate Center, Indianapolis, IN 46285, US
Zymeworks BC Inc. , Suite 800 - 114 East 4th Avenue, Vancouver, BC V5T 1G4, CA
Title
(54) ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES
  ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES